Junzou Kigawa - Gynecology

Author Information

Junzou Kigawa is a prominent researcher affiliated with the Department of Obstetrics and Gynecology at Tottori University, located in Tottori, Japan. His significant contributions to the field of gynecology have made him a well-respected figure in the scientific community.

Research Contributions

Junzou Kigawa's research primarily focuses on gynecological cancers, including cervical and ovarian cancer. His work encompasses various aspects such as chemotherapy treatments, the significance of surgery, and the impact of histological subtypes on cancer survival. Notably, he has also investigated the distribution and association of gBRCA1/2 variants in Japanese ovarian cancer patients. His studies extend to evaluating the utility of cytology and HPV co-testing in cervical cancer screening in Japan and the implementation of primary HPV testing.

Aliases

J Kigawa, J. Kigawa, Junzo Kigawa, Junzou Kigawa

Publication and Citation Metrics

Metric	Value
Citation Count	7804
H-Index	47
Paper Count	292

Publications:

Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study

DOI: 10.1007/s10147-021-01903-1

Year: 2021

Is cytology/HPV co-testing for cervical cancer screening useful in Japan?

DOI: 10.1002/ijgo.13961

Year: 2021

Rethinking the significance of surgery for uterine cervical cancer

DOI: 10.1111/jog.15112

Year: 2021

The first study evaluating the distribution of gBRCA1/2 variants within the ovarian cancer cluster region in Japanese ovarian cancer patients

DOI: 10.1016/j.ygyno.2020.05.632

Year: 2020

Impact of Histological Subtype on Cervical Cancer Survival

DOI:

Year: 2020

Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer

DOI: 10.1007/s10147-020-01787-7

Year: 2020

Implementation of primary HPV testing in Japan

DOI: 10.3892/mco.2020.2092

Year: 2020

Impact of Histopathological Risk Factors on the Treatment of Stage IB-IIB Uterine Cervical Cancer.

DOI: 10.1620/tjem.252.339

Year: 2020

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study

DOI: 10.1111/cas.14513

Year: 2020

The first nationwide Japanese multicenter study: Characterizing the cross-sectional approach to ovarian cancer genetic testing of (CHARLOTTE)

DOI: 10.1016/J.YGYNO.2019.04.074

Year: 2019

How Can Parents and Guardians Support Sex Education?

What Are the Risks of Shaving?

What Are the Challenges of Implementing Cloud-Based EHRs in Gynecology?

What Questions Should Patients Ask Their Gynecologic Oncologist?

What is ISUOG?

How are Ureteral Stents Removed?

How are Fertility Medications Administered?

What is Cancer Staging?

Can Jojoba Oil Be Used During Pregnancy?

What are the Benefits of Automated Reminders?

Partnered Content Networks

Relevant Topics